STOCK TITAN

AN2 Therapeutics to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
AN2 Therapeutics, Inc. (Nasdaq: ANTX) will participate in two upcoming investor conferences in November. Eric Easom, Co-Founder, President and CEO, will provide a corporate overview at the Stifel 2023 Healthcare Conference on November 15 at 3:00 p.m. ET and at the 6th Annual Evercore ISI HealthCONx Conference on November 29 at 8:45 a.m. ET. The presentations can be accessed on the AN2 Therapeutics website.
Positive
  • None.
Negative
  • None.

MENLO PARK, Calif.--(BUSINESS WIRE)-- AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced that company management will participate in two upcoming investor conferences in November.

Stifel 2023 Healthcare Conference

  • Eric Easom, Co-Founder, President and CEO will provide a corporate overview on Wednesday, November 15 at 3:00 p.m. ET.

6th Annual Evercore ISI HealthCONx Conference

  • Eric Easom, Co-Founder, President and CEO will provide a corporate overview on Wednesday, November 29 at 8:45 a.m. ET.

A webcast of the presentations can be accessed on the Investors section of the AN2 Therapeutics website at www.an2therapeutics.com. An archived replay will be available for at least 30 days following the presentation.

About AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. Our initial candidate is epetraborole, which we are studying as a once-daily, oral treatment with a novel mechanism of action for patients with nontuberculous mycobacteria (NTM) lung disease, a rare, chronic, and progressive infectious disease caused by bacteria known as mycobacteria, that leads to irreversible lung damage and can be fatal. For more information, please visit our website at www.an2therapeutics.com.

COMPANY CONTACT:

Lucy O. Day

Chief Financial Officer

l.day@an2therapeutics.com

INVESTOR AND MEDIA CONTACT:

Anne Bowdidge

ir@an2therapeutics.com

Source: AN2 Therapeutics, Inc.

FAQ

Which investor conferences will AN2 Therapeutics participate in November?

AN2 Therapeutics will participate in the Stifel 2023 Healthcare Conference on November 15 and the 6th Annual Evercore ISI HealthCONx Conference on November 29.

Who will provide the corporate overview at the investor conferences?

Eric Easom, Co-Founder, President and CEO of AN2 Therapeutics, will provide the corporate overview at both investor conferences.

Where can the presentations be accessed?

The presentations can be accessed on the Investors section of the AN2 Therapeutics website at www.an2therapeutics.com.

Will there be an archived replay of the presentations?

Yes, an archived replay of the presentations will be available for at least 30 days following the presentation.

AN2 Therapeutics, Inc.

NASDAQ:ANTX

ANTX Rankings

ANTX Latest News

ANTX Stock Data

38.84M
23.24M
21.64%
52.31%
0.45%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
MENLO PARK